GW0742 is a research chemical not approved for human use. It is primarily known as a selective agonist of the PPARδ receptor, a protein that regulates fat metabolism and inflammation. The information below is based on preclinical studies in animal models and cell cultures, and the safety for humans is unknown.
🧬 Key Research Areas for GW0742
●Metabolism and Endurance: GW0742 can increase fatty acid oxidation. In mice fed a high-fat diet, it prevented weight gain, fat accumulation, and improved insulin sensitivity, suggesting a potential role in metabolic disorders. Animal studies also indicate it may improve glucose homeostasis.
●Cardiovascular and Pulmonary Effects: It induces vasorelaxation (widening of blood vessels). In a rat model, it reduced heart hypertrophy caused by high blood pressure in the lungs (pulmonary hypertension), an effect linked to reduced heart stress and improved blood flow. It has also prevented diet-induced hypertension in obese mice.
●Anti-Inflammatory and Organ Protection: The compound has shown potent anti-inflammatory effects in various models. It reduced lung inflammation and reversed damage in a mouse model of emphysema, protected against radiation-induced brain inflammation, reduced nerve cell death in a lab model, and protected cardiac cells from injury.
📊 Summary of Research Findings
| Research Area | Key Finding | Model | Source |
|---|---|---|---|
| Metabolism | Prevents weight gain, fat accumulation, and improves insulin resistance. | High-fat diet-fed mice | |
| Heart & Lungs | Reduces right heart hypertrophy and pulmonary vessel pressure. | Hypoxia-induced pulmonary hypertension in rats | |
| Inflammation | Reduces key inflammatory markers (e.g., IL-1β, TNF-α). | Cell cultures and animal models | |
| Anti-Diabetic | Improves glucose homeostasis and reduces hyperglycemia. | Diabetic rat model | |
| Lung Repair | Reverses lung tissue damage and improves respiratory function. | Emphysema-model mice | |
| Brain Protection | Reduces neuroinflammation after hypoxic-ischemic injury or radiation. | Rat and mouse models | |
| Potential Risk | Induces skeletal muscle damage and liver injury. | Mouse model | |
| Potential Risk | High doses can enhance the inflammatory response. | Mouse model of hemorrhagic shock |
🧪 Current State of Research
GW0742 is not approved for human use and has no established medical applications. Its effects are primarily studied in animals to understand PPARδ's biological roles, with research exploring potential treatments for:
●Metabolic diseases (like obesity and diabetes)
●Cardiovascular and pulmonary diseases (including pulmonary hypertension)
●Inflammatory conditions (such as ischemia/reperfusion injury)
●Neurodegenerative diseases (including stroke and traumatic brain injury)
https://www.hormonerawsource.com/sarm-powders/sarms-powders/superior-quality-gw0742-powder-for.html
